{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:42:45Z","timestamp":1791117765954,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"DOI":"10.1093\/jjco\/hyi244","type":"journal-article","created":{"date-parts":[[2006,3,6]],"date-time":"2006-03-06T20:25:03Z","timestamp":1141676703000},"page":"172-175","source":"Crossref","is-referenced-by-count":59,"title":["Comparison of NMP22 BladderChek Test and Urine Cytology for the Detection of Recurrent Bladder Cancer"],"prefix":"10.1093","volume":"36","author":[{"given":"Atul","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narmada P.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,3,6]]},"reference":[{"key":"key\n\t\t\t\t20171013012023_B1","doi-asserted-by":"crossref","unstructured":"Murphy W, Soloway MS, Jukkola AF. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer1984;53:1555.","DOI":"10.1002\/1097-0142(19840401)53:7<1555::AID-CNCR2820530723>3.0.CO;2-G"},{"key":"key\n\t\t\t\t20171013012023_B2","unstructured":"Cordon-Cardo C, Wartinger DD, Melamed MR, Fair W, Fradet Y. Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low grade superficial bladder tumors. Am J Pathol1992;140:375\u201380."},{"key":"key\n\t\t\t\t20171013012023_B3","doi-asserted-by":"crossref","unstructured":"Soloway MS, Briggman JV, Carpinto GA, et al. Use of a new tumor marker, urinary NMP22 in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol1996;156:363\u20137.","DOI":"10.1016\/S0022-5347(01)65851-8"},{"key":"key\n\t\t\t\t20171013012023_B4","doi-asserted-by":"crossref","unstructured":"Sarosdy MF, Vere White RW, Soloway MS, et al. Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol1995;154:379\u201384.","DOI":"10.1016\/S0022-5347(01)67054-X"},{"key":"key\n\t\t\t\t20171013012023_B5","doi-asserted-by":"crossref","unstructured":"Parry WL, Hemstreet GP. Cancer detection by Quantitative fluorescence image analysis. J Urol1988;139:270\u20134.","DOI":"10.1016\/S0022-5347(17)42384-6"},{"key":"key\n\t\t\t\t20171013012023_B6","doi-asserted-by":"crossref","unstructured":"Guirguis R, Schiffman E, et al. Detection of Autocrine motility factor in urine as a marker of bladder cancer. J Natl Cancer Inst1988;80:1203\u20138.","DOI":"10.1093\/jnci\/80.15.1203"},{"key":"key\n\t\t\t\t20171013012023_B7","doi-asserted-by":"crossref","unstructured":"Muller M, Heine B, Heicappel R, Hummel M, Stein H, Miller K. Telomerase activity in bladder cancer, bladder washings and urine (abstract 187). J Urol1997;157:337.","DOI":"10.3892\/ijo.9.6.1169"},{"key":"key\n\t\t\t\t20171013012023_B8","doi-asserted-by":"crossref","unstructured":"Johnston B, Morales A, Emerson L, Lundie M. Rapid detection of bladder cancer. A comparative study of point of care tests. J Urol1997;158:2098\u2013101.","DOI":"10.1016\/S0022-5347(01)68166-7"},{"key":"key\n\t\t\t\t20171013012023_B9","unstructured":"Urinary bladder. In: American Joint Committee on Cancer: AJCC Cancer Staging Manual, Philadelphia. Lippincott Raven publishers, 5th edition; 1997: pg 241\u20136."},{"key":"key\n\t\t\t\t20171013012023_B10","doi-asserted-by":"crossref","unstructured":"Mostofi FK, Davis CJ, Sesterhenn IA. WHO histologic typing of urinary bladder tumors. Berlin: Springer Verlag; 1999.","DOI":"10.1007\/978-3-642-59871-5"},{"key":"key\n\t\t\t\t20171013012023_B11","doi-asserted-by":"crossref","unstructured":"Lotan Y and Roehrborn CG. Cost- effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the follow up of patients with TCC of the bladder: a decision analytical approach. J Urol2002;167:75.","DOI":"10.1016\/S0022-5347(05)65386-4"},{"key":"key\n\t\t\t\t20171013012023_B12","doi-asserted-by":"crossref","unstructured":"Lotan Y, Roehrborn CG. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta analysis. Urology2003;61:109.","DOI":"10.1016\/S0090-4295(02)02136-2"},{"key":"key\n\t\t\t\t20171013012023_B13","doi-asserted-by":"crossref","unstructured":"Lokeshwar VB, Soloway MS. Current bladder tumor tests: does their prolonged utility fulfill clinical necessity? J Urol2001;165:1067.","DOI":"10.1016\/S0022-5347(05)66428-2"},{"key":"key\n\t\t\t\t20171013012023_B14","doi-asserted-by":"crossref","unstructured":"Jichlinski P. New diagnostic strategies in the detection and staging of bladder cancer. Curr Opin Urol2003;13:351.","DOI":"10.1097\/00042307-200309000-00001"},{"key":"key\n\t\t\t\t20171013012023_B15","doi-asserted-by":"crossref","unstructured":"Lokeshwar VB, Soloway MS. Current bladder tumor tests: does their prolonged utility fulfill clinical necessity? J Urol2001;165:1067.","DOI":"10.1016\/S0022-5347(05)66428-2"},{"key":"key\n\t\t\t\t20171013012023_B16","doi-asserted-by":"crossref","unstructured":"Al- Sukhun S, Hussain M. Molecular biology of TCC. Crit Rev Oncol Haematol2003;47:181.","DOI":"10.1016\/S1040-8428(03)00081-7"},{"key":"key\n\t\t\t\t20171013012023_B17","doi-asserted-by":"crossref","unstructured":"Soloway MS, Briggman JV, Carpinto GA, et al. Use of a new tumor marker, urinary NMP22 in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol1996;156:363\u20137.","DOI":"10.1016\/S0022-5347(01)65851-8"},{"key":"key\n\t\t\t\t20171013012023_B18","doi-asserted-by":"crossref","unstructured":"Berezney R, Coffey DS. Identification of a nuclear protein matrix. Biochem Biophys Res Commun1974;60:1410\u20137.","DOI":"10.1016\/0006-291X(74)90355-6"},{"key":"key\n\t\t\t\t20171013012023_B19","doi-asserted-by":"crossref","unstructured":"Pardoll DM, Vogelstein B, Coffey DS. A fixed site of DNA replication in eukaryotic cells. Cell1980;19:527\u201336.","DOI":"10.1016\/0092-8674(80)90527-9"},{"key":"key\n\t\t\t\t20171013012023_B20","unstructured":"Gordan JN, Shu WP, Schlussel RN. et al. Altered extracellular matrices influece cellular processes and nuclear matrix organizations of overlying human bladder urothelial cells. Cancer Res1993;53:4971\u20137."},{"key":"key\n\t\t\t\t20171013012023_B21","doi-asserted-by":"crossref","unstructured":"Keesee SK, Briggman JV, Thill G et al. Utilization of nuclear matrix proteins for cancer diagnosis. Crit Rev Eukaryot Gene Expr1996;6:189\u2013214.","DOI":"10.1615\/CritRevEukarGeneExpr.v6.i2-3.50"},{"key":"key\n\t\t\t\t20171013012023_B22","doi-asserted-by":"crossref","unstructured":"Stamfer SD, Gennaro A, Lance W Willsey et al. Evaluation of NMP22 in the detection of TCC of bladder. J Urol1998;159:394\u20138.","DOI":"10.1016\/S0022-5347(01)63930-2"},{"key":"key\n\t\t\t\t20171013012023_B23","doi-asserted-by":"crossref","unstructured":"Soloway MS, Briggman JV, Carpinto GA et al. Use of a new tumor marker, urinary NMP22 in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol1996;156:363\u20137.","DOI":"10.1016\/S0022-5347(01)65851-8"},{"key":"key\n\t\t\t\t20171013012023_B24","doi-asserted-by":"crossref","unstructured":"Miyanaga N, Akaza H, Ishikawa S et al. Clinical evaluation of Nuclear Matrix Protein 22 in urine as a novel marker for urothelial cancer. Eur Urol1997;31:163\u20138.","DOI":"10.1159\/000474443"},{"key":"key\n\t\t\t\t20171013012023_B25","doi-asserted-by":"crossref","unstructured":"Landman J, Yongli C, Kavaler E, Droller M, Liu BCS. Sensitivity and specificity of NMP22, Telomerase and BTA in the detection of human bladder cancer. Urology1998;52:398\u2013402.","DOI":"10.1016\/S0090-4295(98)00219-2"},{"key":"key\n\t\t\t\t20171013012023_B26","doi-asserted-by":"crossref","unstructured":"Takashi M, Murase T, Mizuno S et al. Multivariate evaluation of prognostic determinants in bladder cancer patients. Urol Int1987;42:368.","DOI":"10.1159\/000281996"},{"key":"key\n\t\t\t\t20171013012023_B27","doi-asserted-by":"crossref","unstructured":"Rodriguez MF, Toniolo CG, Palou J et al. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol2000;164:680\u20134.","DOI":"10.1016\/S0022-5347(05)67280-1"},{"key":"key\n\t\t\t\t20171013012023_B28","doi-asserted-by":"crossref","unstructured":"Soloway MS, Darren S Bruck, Sandy S Kim. Expectant management of small, recurrent, noninvasive papillary bladder tumors. J Urol2003;170:438\u201341.","DOI":"10.1097\/01.ju.0000076621.71247.6c"},{"key":"key\n\t\t\t\t20171013012023_B29","doi-asserted-by":"crossref","unstructured":"Ponsky LE, Shashikala S, Padrangi L et al. Screening and monitoring for bladder cancer. Refining the use of NMP22. J Urol2001;166:680\u20134.","DOI":"10.1016\/S0022-5347(05)66080-6"},{"key":"key\n\t\t\t\t20171013012023_B30","doi-asserted-by":"crossref","unstructured":"Chen Y, Hayden CL, Marchand KJ et al. Comparison of urine collection methods for evaluating urinary nuclear matrix protein, NMP22 as a tumor marker. J Urol1997;158:1899\u20131901.","DOI":"10.1016\/S0022-5347(01)64164-8"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/36\/3\/172\/5162232\/hyi244.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T02:07:09Z","timestamp":1555466829000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jjco\/article\/36\/3\/172\/865547\/Comparison-of-NMP22-BladderChek-Test-and-Urine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,1]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,3,6]]},"published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyi244","relation":{},"ISSN":["1465-3621","0368-2811"],"issn-type":[{"value":"1465-3621","type":"electronic"},{"value":"0368-2811","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,3]]},"published":{"date-parts":[[2006,3,1]]}}}